Figure 2From: Using clinical trial data and linked administrative health data to reduce the risk of adverse events associated with the uptake of newly released drugs by older Australians: a model process Vascular co-medication exclusion protocols applied in the efficacy clinical trials of rofecoxib, by arthritis type.Back to article page